SIGN-UP NOW! SIGN-UP NOW! Click to become a VoiceAmerica Member for Free!
Voiceamerica radio logo
voiceamerica-business radio logo
Apple logo Google Play Store Kindle store
The Ellis Martin Report

The Ellis Martin Report

Shows added weekly

May 20th 2015:Special Encore Presentation: David Morgan, Nobilis Health, Oncolytics Biotech and BacTech Environmental

Today on the program Ellis speaks with Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors while leaving healthy cells alone. He’ll chat with Harry Fleming, Executive Chairman of Texas based Nobilis Health Trading on the NYSE as HLTH. Nobilis has successfully developed a cadre of boutique surgical centers in Houston, Dallas and Phoenix. Ross Orr, President of Bactech Environmental, trading on the Otc as BCCEF and on the Canadian Stock Exchange as BAC will discuss

Read more
Share Email SHARE
Download PDF DOWNLOAD PDF
Get Code GET CODE

Tune in

Shows added weekly on VoiceAmerica Business Channel
EPISODE ON DEMAND
VIEW HOST PAGE

Featured Guests

Guest Image

Ross Orr

Ross Orr initially brought BacTech Mining Corporation to Canada from Australia in 1997 and was instrumental in the success of the Company's IPO. He sat on the board as an outside Director until taking the role of President and CEO in 2006. Following completion of the Plan of Arrangement in December 2010 which split BacTech Mining into two new companies, REBgold Corporation and BacTech Environmental Corporation, Mr. Orr assumed the position of President & CEO of BacTech Environmental. Mr. Orr is a graduate of the University of Calgary.
Read more
Guest Image

Harry Fleming

President of Nobilis Health Mr. Fleming has over 25 years of legal and business experience in corporate finance and securities law, focusing much of his career on emerging growth companies, mergers and acquisitions, strategic business planning and turnaround execution. His background includes venture capital representation, business strategy consulting, public company representation, as well as mergers and acquisitions with high tech firms in Houston and Boston. Additionally, he has extensive experience with consolidating companies in the healthcare, energy, and waste management industries. As CEO, President, CFO and General Counsel for several public and private companies, Fleming has
Read more
Guest Image

Dr. Brad Thompson

Chairman, President & Chief Executive Officer of Oncolytics Biotech, Inc. Dr. Thompson has held the positions of Chairman of the Board, President and Chief Executive Officer of Oncolytics Biotech Inc. since April 1999. He has provided leadership to various organizations within the biotechnology sector for more than twenty years. Prior to his role with Oncolytics, Dr. Thompson was the Chief Executive Officer of SYNSORB Biotech from 1994 to 1999. From 1983 to 1994, Dr. Thompson worked in a senior role at the Alberta Research Council. He is a current member and Emeritus Chairman of BIOTECanada and sits on the boards of various other biotechnology companies. He received his PhD from the Uni
Read more
Guest Image

David Morgan

A precious metals aficionado armed with degrees in finance and engineering, he created TheMorganReport.com website and originated The Morgan Report, a monthly that covers economic news, overall financial health of the global economy, currency problems, and the key reasons for investing in the Resource Sector. David considers himself a big-picture macroeconomist whose main job is education—educating people about honest money and the benefits of a sound financial system.
Read more

Share This Episode

facebook Share On Facebook
twitter Share On Twitter
Linkedin Share On LinkedIn
Share Email Share this E-mail
Email Host Email the Host

Connect with VoiceAmerica

Download our mobile apps
App store Google play Blackberry store
GPlus Facebook Twitter Linkedin Social Media
Va Press pass